3 results

• Copiktra Side Effects Too Dangerous for Some Cancer Patients, FDA Advisory Committee Decides

  September 26, 2022

  Russell Maas

  An FDA advisory committee voted to recommend the agency not approve Copiktra for some blood cancer patients due to an increased risk of death.

• Cancer Drug Copiktra Could Shorten Life Expectancy in Some Patients, FDA Reviewers Warn

  September 23, 2022

  Irvin Jackson

  An advisory committee is being asked to review the benefits and risks of Copiktra, a blood cancer drug FDA experts say appears to lower life expectancy in some cancer patients.

• Cancer Drug Copiktra Linked To Increased Risk of Death, FDA Warns

  July 1, 2022

  Martha Garcia

  The FDA warns the cancer drug, Copiktra, may be linked to an increased risk of death among patients.